MedTrace Logo

Cognitive AppRoaches to coMbatting Suicidality

NCT03114917 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 329

Last updated 2023-05-10

No results posted yet for this study

Summary

This is a randomised controlled trial which investigates the effectiveness of CARMS (Cognitive AppRoaches to coMbatting Suicidality) therapy in reducing suicidal thoughts and how well CARMS works in practice within the NHS. The trial will compare two groups of people with psychosis who are using NHS mental health services. One group will carry on with their usual treatment. The other group will be offered 24 weekly sessions of CARMS therapy, plus their usual treatment.

Conditions

Interventions

OTHER

Cognitive AppRoaches to coMbatting Suicidality (CARMS)

The investigators' psychological therapy is a recovery-focused, structured, time-limited, socio-cognitive intervention. It is based upon the investigators' recently developed treatment manual (Tarrier et al., 2013) and pilot RCTs in the community (Tarrier et al., 2014) and in prison (Tarrier et al., accepted). The intervention modifies negative appraisals of emotional regulation, social support, and interpersonal problem-solving. As a consequence, perceptions of defeat, entrapment, and hopelessness will be improved indirectly. In addition, perceptions of defeat, entrapment, and hopelessness will be worked on directly during the therapy.

Sponsors & Collaborators

  • Greater Manchester Mental Health NHS Foundation Trust

    collaborator OTHER

  • Lancaster University

    collaborator OTHER

  • University of Manchester

    lead OTHER

Principal Investigators

  • Patricia Gooding · University of Manchester

  • Gillian Haddock · University of Manchester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-12
Primary Completion
2022-01-27
Completion
2022-01-27

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03114917 on ClinicalTrials.gov